Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Front Neurol ; 12: 601996, 2021.
Article in English | MEDLINE | ID: mdl-33679575

ABSTRACT

Background: Patients with poor-grade aneurysmal subarachnoid hemorrhage (aSAH), defined as World Federation of Neurosurgical Societies (WFNS) grades IV-V have high rates of disability and mortality. The objective of this study was to accurately prognosticate the outcomes of patients with poor-grade aSAH by developing a new scoring model. Methods: A total of 147 poor-grade aSAH patients in our center were enrolled. Risk variables identified by multivariate logistic regression analysis were used to devise a scoring model (total score, 0-9 points). The scores were estimated on the basis of ß coefficients. A cohort of 68 patients from another institute was used to validate the model. Results: Multivariate logistic regression analysis revealed that modified Fisher grade >2 [odds ratio [OR], 2.972; P = 0.034], age ≥65 years (OR, 3.534; P = 0.006), conservative treatment (OR, 5.078; P = 0.019), WFNS grade V (OR, 2.638; P = 0.029), delayed cerebral ischemia (OR, 3.170; P = 0.016), shunt-dependent hydrocephalus (OR, 3.202; P = 0.032), and cerebral herniation (OR, 7.337; P < 0.001) were significant predictors for poor prognosis [modified Rankin Scale [mRS] ≥3]. A scoring system was constructed by the integration of these factors and divided the poor-grade aSAH patients into three categories: low risk (0-1 points), intermediate risk (2-3 points), and high risk (4-9 points), with predicted risks of poor prognosis of 11, 52, and 87%, respectively (P < 0.001). The area under the curve in the derivation cohort was 0.844 (95% CI, 0.778-0.909). The AUC in the validation cohort was 0.831 (95% CI, 0.732-0.929). Conclusions: The new scoring model can improve prognostication and help decision-making for subsequent complementary treatment in patients with aSAH.

2.
Front Neurol ; 11: 527323, 2020.
Article in English | MEDLINE | ID: mdl-33192965

ABSTRACT

Objective: The endoscopic transsphenoidal pituitary surgery has gained popularity and has shown excellent results with a more comfortable postoperative course. However, the quality of the early postoperative course is not well-established in endoscopic transsphenoidal pituitary surgery. We hypothesized that the quality of the early postoperative course would be improved when an enhanced recovery after surgery (ERAS) protocol and minimally invasive endoscopic transsphenoidal pituitary surgery is implemented. Methods: We implemented a perioperative management ERAS protocol for endoscopic transsphenoidal pituitary surgery by an experienced surgeon (Yuehui Ma) in our department from January 2018. From then the endoscopic transsphenoidal pituitary surgery was implemented with a minimally invasive technique, such as bony sella reconstruction and partial nasal packing. We compared the results of 78 endoscopic transsphenoidal pituitary surgery cases during the initiation of the ERAS protocol and minimally invasive technique implementation: 37 cases in the control group and 41 cases in the ERAS group. Outcomes assessed included the effectiveness and security of surgery, postoperative hospital length of stay (LOS), and postoperative status on postoperative day 1 (POD1). Results: Postoperative status on POD1, such as nasal ventilation, out of bed, headache score, and liquid supplement, had significant improvement (P < 0.05). The median postoperative LOS decreased from 8 days in the control group to 3 days in the ERAS group (P < 0.05). The ERAS group had better economic benefit with fewer hospital charges (P < 0.05). There was no difference in the early postoperative diabetes insipidus and 30-day readmission for epistaxis, hyponatremia, or other complications between the two groups. Conclusion: The quality of the early postoperative course was improved when a neurosurgical ERAS protocol and minimally invasive endoscopic transsphenoidal pituitary surgery with partially nasal packing were implemented. Endoscopic transsphenoidal pituitary day surgery could be recommended in some classes of patients though further evaluation in large case studies is warranted.

3.
Medicine (Baltimore) ; 99(47): e23405, 2020 Nov 20.
Article in English | MEDLINE | ID: mdl-33217885

ABSTRACT

RATIONALE: Intrasellar cavernous hemangiomas (ICHs) are rare vascular lesions that arise in the sellar region. ICHs are usually misdiagnosed and treated as pituitary adenomas. Therefore, a preoperative diagnosis is particularly important, especially when the goal is complete resection. PATIENT CONCERNS: A 55-year-old woman presented with a 1-month history of intermittent dizziness. Magnetic resonance imaging (MRI) revealed a well-demarcated abnormal ellipsoid signal in the sellar region (size: 2.7 cm × 1.7 cm), with a mulberry-like enhancement after gadolinium injection. Computed tomography revealed an intrasellar mass without calcification that extended into the left cavernous sinus and was faintly contrast-enhanced. Angiography revealed a tumor with mildly delayed staining fed by the C5 segment of the right internal carotid artery. DIAGNOSIS: An intrasellar cavernous hemangioma based on neuroradiological examinations. INTERVENTIONS: The patient underwent surgery with an endoscopic endonasal transsphenoidal approach to debulk the lesion and obtain tissue for the pathological diagnosis. OUTCOMES: Blood spurting was observed after puncture, and the capsule was stained blue. Lesion removal was stopped, and the patient underwent gamma knife surgery 1 week later. She remained in good condition during the follow-up. LESSONS: Sponge-like or mulberry-like lesions can be identified on MRI after gadolinium injection and can facilitate a preoperative diagnosis of ICH. Currently, surgical debulking with cranial nerve decompression during the acute stage and subsequent gamma knife radiosurgery are considered to be a safe and effective treatment.


Subject(s)
Hemangioma, Cavernous/diagnostic imaging , Sella Turcica/diagnostic imaging , Cerebral Angiography , Computed Tomography Angiography , Contrast Media , Diagnosis, Differential , Endoscopy , Female , Hemangioma, Cavernous/surgery , Humans , Magnetic Resonance Imaging , Middle Aged
4.
BMC Surg ; 19(1): 142, 2019 Oct 10.
Article in English | MEDLINE | ID: mdl-31601219

ABSTRACT

BACKGROUND: Eccrine porocarcinoma is an extremely rare skin adnexal malignant neoplasia with highly invasive and metastatic potential. We report an additional case of eccrine porocarcinoma with intracranial metastases. This case is characterized by a complete record of the progress of eccrine porocarcinoma, its immunohistochemistry after three operations showed a progressive increase in the level of Ki-67 index. CASE PRESENTATION: We herein report a case of a 37-year-old-male with eccrine carcinoma occurring on the left posterior occipital scalp which invaded the skull and dura, presenting with progressive headache. This patient has performed three surgeries in total. During the last hospitalization, he underwent an extended surgical resection, lymphadenectomy, myocutaneous flap transplantation and vascular anastomosis in our institution. After surgery, he was treating with radiotherapy at 200 Gray in 12 fractions. But one year after the operation, he developed chest tightness, imaging examination and biopsy puncture revealed pulmonary metastasis. CONCLUSION: Intracranial metastasis of eccrine porocarcinoma is a late event with poor prognosis. This case emphases on that progressively increased level of Ki-67 index may predict more chance to occur the intracranial metastasis of scalp eccrine porocarcinoma, long-term follow-up and appropriately dense follow-up interval is necessary.


Subject(s)
Eccrine Porocarcinoma/pathology , Ki-67 Antigen/metabolism , Sweat Gland Neoplasms/pathology , Adult , Humans , Immunohistochemistry , Lymph Node Excision , Male , Skin Neoplasms/pathology
5.
BMC Neurol ; 16: 158, 2016 Sep 01.
Article in English | MEDLINE | ID: mdl-27586248

ABSTRACT

BACKGROUND: Timely diagnosis of meningeal carcinomatosis is often difficult even with the assistant of magnetic resonance imaging examination, cerebrospinal fluid analysis, or both. To the best of our knowledge, gadobutrol-enhanced MRI has not been reported in the diagnosis of meningeal carcinomatosis. Here we present two cases where meningeal carcinomatosis was identified on gadobutrol-enhanced magnetic resonance imaging. CASE PRESENTATION: We identified two cases of meningeal carcinomatosis who had been diagnosed with malignant tumors several years ago. Both patients presented with progressive headache and seizures. Gadopentetate dimeglumine-enhanced magnetic resonance imaging of the brain was performed and did not detect any abnormality of meninges. Lumbar puncture was performed repeatedly, but cerebrospinal fluid cytology showed no evidence of malignant cells. Finally the gadobutrol-enhanced magnetic resonance imaging detected the meningeal metastasis, and supported the diagnosis of meningeal carcinomatosis. CONCLUSION: Gadobutrol provides higher lesion conspicuity and enhances lesion detection in meningeal metastasis compared with gadopentetate dimeglumine. Our observation is a cue to analyze the accuracy in the diagnosis of meningeal carcinomatosis, and presents a choice that may facilitate early diagnosis.


Subject(s)
Gadolinium DTPA , Magnetic Resonance Imaging/methods , Meningeal Carcinomatosis/diagnostic imaging , Organometallic Compounds , Adult , Early Diagnosis , Female , Humans , Middle Aged , Spinal Puncture
6.
Turk Neurosurg ; 23(4): 534-8, 2013.
Article in English | MEDLINE | ID: mdl-24101278

ABSTRACT

Primary spinal melanoma (PSM) is rare and usually occurs in the cervical and thoracic regions. Here, we present a case of multiple spinal cord melanoma located at the level of cervical and upper thoracic spine in a 24-year-old male. The patient underwent a T6-T7 thoracic laminectomy and gross-total resection of the duty lesion. The histological findings of the tumor were consistent with an intermediate-grade melanocytoma. To the best of our knowledge, only two cases of multifocal primary melanocytic tumor have been reported in the literature. In this case study we review the pertinent literature and emphasize the importance and difficulties concerning the preoperative diagnosis of multiple PSM.


Subject(s)
Melanoma/diagnosis , Melanoma/surgery , Neurosurgical Procedures/methods , Spinal Cord Neoplasms/diagnosis , Spinal Cord Neoplasms/surgery , Diagnosis, Differential , Humans , Laminectomy , Male , Melanoma/pathology , Spinal Cord/pathology , Spinal Cord Neoplasms/pathology , Treatment Outcome , Young Adult
7.
Guang Pu Xue Yu Guang Pu Fen Xi ; 22(4): 651-4, 2002 Aug.
Article in Chinese | MEDLINE | ID: mdl-12938389

ABSTRACT

This paper studied mechanism of Ce3+, Cd2+, Pb2+ on RNase activity from bovine pancreas. The results showed that the activity of RNase was enhanced under the treatment by Ce3+, Cd2+, Pb2+ at lower concentration (10-60 or 10-30 mumol.L-1), but was inhibited by Ce3+, Cd2+, Pb2+ at higher concentration (40 or 70 mumol.L-1 above), and the inhibition was in the order as Pb2+ > Cd2+ > Ce3+. The equilibrium dialysis demonstrates that RNase may have one Ca(2+)-binding site. The fluorescence titration showed that one molecule of RNase has one binding site for Ce3+, the association constant k for its low-affinity Ce(3+)-binding site is 1.22 x 10(8) L.mol-1. However, it can bind three Cd2+ or Pb2+ and the association causing constant k for its low-affinity Cd2+ or Pb(2+)-binding site is 1.8 x 10(8) L.mol-1, 2.01 x 10(8) L.mol-1, respectively, and caused the conformational changes of RNase.


Subject(s)
Metals, Heavy/chemistry , Ribonuclease, Pancreatic/chemistry , Ribonucleases/chemistry , Animals , Binding Sites , Cadmium/chemistry , Calcium/chemistry , Cattle , Cerium/chemistry , Lead/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...